FDA Expands Bayer’s Kerendia Approval to Chronic Kidney Disease Associated With Type 1 Diabetes
The FDA has approved Bayer's Kerendia (finerenone) for chronic kidney disease associated with type 1 diabetes, the first new treatment for this patient group in over 30 years, based on…
